Skip to content

Effect of Bra Use During Radiotherapy for Breast Cancer Radiotherapy

Effect of Bra Use During Radiotherapy for Breast Cancer Radiotherapy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06178861
Enrollment
38
Registered
2023-12-21
Start date
2022-12-01
Completion date
2024-10-20
Last updated
2025-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Radiation Therapy

Brief summary

This prospective randomized study investigated the reproducibility of breast shape, radiation dose irradiated to the lungs, heart, dose distribution, patient satisfaction, and treatment toxicity when wearing and not wearing a bra during radiotherapy for patients with breast cancer.

Detailed description

Post-surgery radiotherapy to the breast is standard treatment after breast-conserving surgery in patients with breast cancer. In order to apply the latest radiation therapy technologies, such as intensity-modulated radiotherapy, it is important to maintain the correct posture. However, due to the nature of the breast made of soft tissue, it is difficult to maintain the same breast shape during each treatment. This is especially difficult for large, ptotic breasts. Accordingly, we developed a bra for breast cancer patients in order to perform accurate radiotherapy. It was designed to fix the breast using bands in various directions so that its shape and position can be fixed during radiation treatment. This is a prospective, randomized controlled study to evaluate the effects of using a bra for breast cancer patients on the reproducibility of breast shape, radiation dose irradiated to the lungs, heart, dose distribution, patient satisfaction, and treatment toxicity.

Interventions

DEVICEGroup wearing a radiotherapy bra

Group wearing a radiotherapy bra

Sponsors

Yonsei University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Masking description

Test group: Group wearing a radiotherapy bra / Control group: Group not wearing a radiotherapy bra -Allocation: Random -Blinding: None -Time: Prospective

Intervention model description

Test group: Group wearing a radiotherapy bra / Control group: Group not wearing a radiotherapy bra -Allocation: Random -Blinding: None -Time: Prospective

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

1. Patients with histologically confirmed invasive breast cancer or ductal carcinoma in situ 2. Patients eligible for whole breast irradiation after partial mastectomy 3. Adults over 20 years old 4. Patients with good overall performance (ECOG PS 0-1)

Exclusion criteria

1. Recurrent breast cancer patients 2. Patients who have previously received radiation therapy to the ipsilateral breast 3. Patients who underwent breast reconstruction 4. Bilateral breast cancer 5. Patients with skin diseases such as contact dermatitis

Design outcomes

Primary

MeasureTime frameDescription
The reproducibility of breast shape through cross-correlation values, both with and without the use of a braDuring the radiotherapy, an average of 1 monthEvaluating the reproducibility of breast shape through cross-correlation values in cone-beam CT and planning CT matching. This study involves comparing groups of patients wearing and not wearing a bra

Secondary

MeasureTime frameDescription
Radiation dosimetric evaluationat the time of completion of radiotherapyradiation dose to lungs, heart and breast
Patient satisfaction assessmentat the time of completion of radiotherapy1. Survey on anxiety before and after radiation treatment (using STAI, APAIS, and LASA scales) 2. Survey on satisfaction with radiotherapy bra after radiation therapy
Assessment of treatment toxicityat 6 months and 12 months after the radiotherapy1. Acute toxicity grade 2 or higher according to CTCAE version 5.0 2. Late toxicity grade 2 or higher according to CTCAE version 5.0

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026